New Initiative Expands Access to Life Saving Drug-Resistant Tuberculosis Treatment

resisttb
Jul 1
1 min read

With the new $7.3 million Unitaid investment, Partners In Health (PIH) is beginning a new initiative to improve care and quality of life for people suffering from drug-resistant tuberculosis (DR-TB). One project in particular, the Accelerating Regimens and Care for DR-TB (arcTB), will focus on the testing and treatment sides of DR-TB. Read more here.

Recent Posts

See All

TB Experts Rally Around New, Shortened TB Treatments

A regional training session for 20 countries has been successfully completed in Lima, Peru convened by PeerLNC, a global knowledge hub...

Open letter: Experts call for urgent expansion of Pretomanid label

Despite trials like TB-PRACTECAL displaying the efficacy of pretomanid in the expanded BPaLM regimen, the EMA only approved for the BPaL...

WHO Accelerator Platform for Novel TB Regimens

The meeting of the WHO Accelerator Platform for Novel TB Regimens will be held on Thursday, 8 May 2025, from 14.00 to 15.30 (CET). Main...

Comments